Treating a limb-threatening arterial clot in a newborn with catheter-directed thrombolysis Grace MurrayOmri David SofferChittalsinh Raulji OriginalPaper 06 March 2023 Pages: 589 - 591
Evaluating chest pain in patients with post COVID conditions permission to think outside of the box Richard C Becker Editorial 13 April 2023 Pages: 592 - 603
Risk adjusted venous thromboembolism prophylaxis following pancreatic surgery Abigail PohlAaron C. SpauldingMichael A. Edwards OriginalPaper 25 January 2023 Pages: 604 - 616
Unfractionated heparin versus enoxaparin for venous thromboembolism prophylaxis in intensive care units: a propensity score adjusted analysis Sophie SamuelWen LiLouise D. McCullough OriginalPaper 08 April 2023 Pages: 617 - 625
Effects of uridine and nucleotides on hemostasis parameters Merve ArıEngin SağdilekKasım Özlük OriginalPaper 24 March 2023 Pages: 626 - 633
Up-regulated lncRNA SNHG9 mediates the pathogenesis of dilated cardiomyopathy via miR-326/EPHB3 axis Fan zhangHongtao ShiQinghua Han OriginalPaper 01 April 2023 Pages: 634 - 648
An exploratory study of effectiveness and safety of rivaroxaban in patients with left ventricular thrombus (R-DISSOLVE) Qing YangXin QuanYan Liang OriginalPaper 20 March 2023 Pages: 649 - 659
First use of large-bore suction thrombectomy for acute pulmonary embolism in Asia-Pacific: feasibility and short-term clinical outcomes Pipin KojodjojoHean Ann OngYinghao Lim OriginalPaper 05 April 2023 Pages: 660 - 666
Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy M. BerteottiA. M. GoriR. Marcucci OriginalPaper Open access 11 March 2023 Pages: 667 - 679
Adverse events in low versus normal body weight patients prescribed apixaban for atrial fibrillation Deborah DeCamilloBrian HaymartGeoffrey D Barnes OriginalPaper 30 January 2023 Pages: 680 - 684
DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network Karlyn A MartinNicola LanckiRachel P. Rosovsky OriginalPaper 09 February 2023 Pages: 685 - 690
Differences in referral to a chronic thromboembolic pulmonary hypertension center following acute pulmonary embolism: a locoregional experience Ruben MylvaganamRomy LawrenceMichael J. Cuttica OriginalPaper 12 February 2023 Pages: 691 - 699
A scoping review of direct oral anticoagulant ambulatory management practices Jasmine S. MangrumJohn A. SaundersJordan B. King ReviewPaper 28 March 2023 Pages: 700 - 709
Efficacy and safety of prophylaxis for venous thromboembolism in brain neoplasm patients undergoing neurosurgery: a systematic review and Bayesian network meta-analysis Deshan LiuDixiang SongHongwei Zhang ReviewPaper 10 February 2023 Pages: 710 - 720
A retrospective evaluation of direct oral anticoagulant (DOAC) management strategies in patients with cancer on active chemotherapy Emmeline TranLauren E. Ledbetter BriefCommunication 12 February 2023 Pages: 721 - 728
Direct oral anticoagulants in patients with venous thromboembolism and hematological malignancies Renana RobinsonGalia SpectreAvi Leader OriginalPaper 21 March 2023 Pages: 729 - 736
Association of hyponatremia with clinical outcomes in patients admitted with acute pulmonary embolism Vaishali DeenadayalanSadichhya KarkiMaryam Zia OriginalPaper 06 February 2023 Pages: 737 - 741
Recent trends in tranexamic acid use during postpartum hemorrhage in the United States Ethan A. LitmanPhillip MaHoma. K. Ahmadzia BriefCommunication 24 February 2023 Pages: 742 - 746
Atrial fibrillation risk on Parkinson’s disease – a systematic review and meta-analysis Fátima CerejaMariana AlvesDaniel Caldeira BriefCommunication 25 March 2023 Pages: 747 - 750
Management and outcomes of women with antiphospholipid syndrome during pregnancy Jacqueline J. TaoSanjana AdurtyMaria T. DeSancho OriginalPaper 27 March 2023 Pages: 751 - 759
Chronic kidney disease and thrombotic risk in patients with chronic myeloproliferative neoplasms Marko LucijanicIvan Krecak Letter to the Editor 06 February 2023 Pages: 760 - 761
Acetylsalicylic acid challenge or desensitization in sensitive patients with cardiovascular disease Gabriele CortelliniAlberto RaiteriAntonino Romano OriginalPaper 09 February 2023 Pages: 762 - 769
Acquired von willebrand syndrome secondary to monoclonal gammopathy of undetermined significance: long-term remission after treatment with bortezomib Artur SaldanhaMaria Eduarda VeigaPaula Villaca Letter to the Editor 31 March 2023 Pages: 770 - 774
Correction to: DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network Karlyn A MartinNicola LanckiRachel P. Rosovsky Correction 30 March 2023 Pages: 775 - 775